Zarlink Semiconductor Inc.
TSX : ZL
OTC Bulletin Board : ZARLF

Zarlink Semiconductor Inc.

November 22, 2010 09:31 ET

Zarlink Simplifies Design of Wirelessly Enabled Implanted Medical Devices and Monitoring Equipment

ZLE70102 ADK (Application Development Kit) allows customers to easily evaluate performance of medical wireless systems built using Zarlink's radio technology

OTTAWA, CANADA--(Marketwire - Nov. 22, 2010) - Zarlink Semiconductor (TSX:ZL) today introduced a new application development kit that helps customers speed the design and evaluation of wireless telemetry systems linking implanted medical devices and home monitoring and programming equipment.

"Customers are designing our wireless radio technology into approved applications, including pacemakers and implantable cardiac defibrillators, and a widening range of new devices such as cardiac monitors and neuromodulation systems," said Steve Swift, senior vice president and general manager of Zarlink's Medical Products Group. "Our new application development kit offers customers a complete hardware and software solution to speed the development of ultra low-power, highly reliable and standards compliant medical communication systems built on Zarlink's proven medical wireless expertise."

The ZLE70102 ADK supports full speed data test, link statistics and power monitoring of end-to-end medical communications telemetry systems enabled by the ZL70102 (Medical Implant Communication Service) radio platform. The application development kit allows customers to evaluate wireless performance in a range of environments and adjust algorithms to reduce overall power consumption.

Designed into wirelessly enabled pacemakers, Zarlink's radio chip routinely transmits patient health and device performance data to a home base station. Data is then forwarded to a physician's office. During surgery to implant medical devices, the extended wireless operating range of the ZL70102 MICS radio solution allows programming equipment to be located outside the sterile operating field.

The ZL70102 MICS radio delivers advanced performance to help conserve battery life for wirelessly enabled implanted medical devices. In full operation, the ZL70102 radio chip consumes just 5 mA (milliamps) of supply current. Over a typical seven year operating life of an implanted medical device, the ZL70102 device will consume the same amount of energy required to power a 40-watt light bulb for just 10 seconds.

The ZLE70102 ADK includes all hardware and firmware required to enable rapid evaluation, prototyping and development of end-to-end medical communications telemetry systems using the ZL70102 MICS transceiver. For a complete description of the ZLE70102 ADK, visit http://www.zarlink.com/zarlink/hs/82_ZLE70102.htm.

About Zarlink Semiconductor

Zarlink Semiconductor delivers world-leading, mixed-signal chip technologies for a broad range of communication and medical applications. The Company's core capabilities include network timing solutions that manage time-sensitive communication applications over wireless and wired networks, line circuits supporting high-quality voice services over cable and broadband connections, and ultra low-power radios enabling new wireless medical devices and therapies. Serving the world's largest original equipment manufacturers, Zarlink's highly integrated chip solutions help customers simplify design, lower costs and reach market quickly. For more information, visit www.zarlink.com.

Shareholders and other individuals wishing to receive, free of charge, copies of the reports filed with the U.S. Securities and Exchange Commission and Canadian Securities Regulatory Authorities, should visit the Company's web site at www.zarlink.com or contact Investor Relations.

Certain statements in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such risks, uncertainties and assumptions include, among others, the following: our dependence on the successful development and market introduction of new products; our ability to integrate any business, technologies, product lines or services that we have or will acquire; our dependence on revenue generation from our legacy products in order to fund development of our new products; current market conditions, including the lack of liquidity in the markets and economic slowdown, may increase our operating costs or reduce our revenue, thereby negatively impacting our operating results; our ability to operate profitably and generate positive cash flows in the future; the impact of the current economic crisis on our suppliers and customers and our ability to transfer parts to other suppliers; our dependence on our foundry suppliers and third-party subcontractors; order cancellations and deferrals by our customers; our substantial indebtedness could adversely affect our financial position; the cost and accounting implications of compliance with new accounting standards; and other factors referenced in our Annual Report on Form 20-F. Investors are encouraged to consider the risks detailed in this filing.

Zarlink and the Zarlink Semiconductor logo are trademarks of Zarlink Semiconductor Inc.

Contact Information